Skip to main content

Table 1 Demographic and clinical characteristics of the study population

From: Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings

Variable Study Population
N = 97
HIV/HCV
N = 11
HCV
N = 86
Gender n (%)
 Female 55 (57) 07 (64) 48 (56)
 Male 42 (43) 04 (36) 38 (44)
Mean age in years 60.2 58.9 60.4
Mean AST (UI/L) 60.3 (7–259) 73.6 (26–179) 58.5 (07–259)
Mean platelet × 103 (UI/L) 172 (50–369) 138 (57–227) 177 (50–369)
Mean APRI score 1.1 (0.1–5.4) 1.7 (0.4–5.4) 1 (0.1–3.6)
Stage F0 n (%) 36 (37.1%) 03 (27.3%) 33 (38.4%)
Stage F1 n (%) 20 (20.6%) 01 (09.1%) 19 (22.1%)
Stage F2 n (%) 11 (11.3%) 00 (0.0%) 11 (12.8%)
Stage F3 n (%) 13 (13.4%) 04 (36.3%) 9 (10.5%)
Stage F4 n (%) 17 (17.5%) 03 (27.3%) 14 (16.2%)